Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...

Mylan has paid $96.5 million to settle claims it delayed launching a generic of narcolepsy drug Provigil in exchange for a payment from the originator, Cephalon. Reuters reported the settlement ...

A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

Hetero and Mylan, a subsidiary of Viatris, ensures that, once approved, generic versions of the drug will be made available ...

GATC West Virginia is making progress in medical innovation at its headquarters in the WVU Innovation Corp. Their lab is up ...

Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped ...